By Ptilast Updated
Emcure Pharmaceuticals and Sanofi India have announced a distribution agreement. Emcure will promote Sanofi India’s oral anti-diabetic products like Amaryl and Cetapin. Sanofi India will continue to manufacture these brands. This collaboration aims to make these medicines more accessible across India. The partnership will benefit patients and healthcare professionals. There will be no staff transition from Sanofi India to Emcure.